The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

Pain

Volumn 76, Issue 1-2, 1998, Pages 189-199

  Jaggar, Siân I ^a   Hasnie, Fauzia S ^a   Sellaturay, Senthy ^a   Rice, Andrew S C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Analgesia; Autacoid local inflammation antagonism; Mast cell; Nerve growth factor; Nociception; Rat

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR AGONIST; PALMIDROL; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; FEMALE; HYPERALGESIA; INFLAMMATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; VISCERAL PAIN;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CAPILLARY PERMEABILITY; CYSTITIS; ELECTROPHYSIOLOGY; FEMALE; FORMALDEHYDE; HYPERALGESIA; INFLAMMATION; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; URINARY BLADDER;

EID: 0031776783     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00041-4     Document Type: Article

References (78)

1. Abood M.E., Martin B.R. Molecular neurobiology of the cannabinoid receptor. Int. Rev. Neurobiol. 39:1996;197-221.
2. Aloe L., Tuveri M., Cacassi U., Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 35:1992;351-355.
3. Aloe L., Leon A., Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions. 39:1993;C145-C147.
4. Andreev N.Y., Bennett D.L.H., Priestley J.V., McMahon S.B. NGF m-RNA is increased by experimental inflammation of adult rat urinary bladder. Soc. Neurosci. Abstr. 20:1994;108.18.
5. Andreev N.Y., Dmitrieva N., Rice A.S.C., McMahon S.B. Peripheral administration of morphine reduces the consequences of inflammation produced by turpentine in the adult rat urinary bladder. Soc. Neurosci. Abstr. 21:1995;536.4.
6. Bayewitch M., Avidor-Reiss T., Levy R., Mechoulam R., Barg J., Vogel Z. Activation of the peripheral cannabinoid receptor (CB2) inhibits adenylate cyclase. Soc. Neurosci. Abstr. 21:1995;2608.
7. Bianchi M., Panerai A.E. The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. Br. J. Pharmacol. 117:1996;130-132.
8. Birder L.A., De Groat W.C. The effect of glutamate antagonists on c-fos expression induced in spinal neurons by irritation of the lower urinary tract. Brain Res. 580:1992;115-120.
9. Bouaboula M., Rinaldi M., Carayon P., Carillon C., Delpech B., Shire D., Le Fur G., Casallas P. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214:1993;173-180.
10. Coderre T.J., Melzack R. The contribution of excitatory amino acids to central sensitisation and persistent nociception after formalin-induced tissue injury. J. Neurosci. 12:1992;3665-3670.
11. Devane W.A. New dawn of cannabinoid pharmacology. Trends Pharmacol. Sci. 15:1994;40-41.
12. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
13. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
14. Dickenson A.H., Sullivan A.F. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain. 31:1987;349-360.
15. Dmitrieva N., McMahon S.B. Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain. 66:1996;87-97.
16. Dmitrieva N., Iqbal R., Shelton D.L., McMahon S.B. c-fos induction in a rat model of cystitis: role of NGF. Soc. Neurosci. Abstr. 22:1996;751.
17. Dmitrieva N., Shelton D.L., Rice A.S.C., McMahon S.B. The role of nerve growth factor in a model of visceral inflammation. Neuroscience. 78:1997;449-459.
18. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
19. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA. 92:1995;3376-3380.
20. Felder C.C., Briley E.M., Axelrod J., Simpson J.T., Mackie K., Devane W.A. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor mediated signal transduction. Proc. Natl. Acad. Sci. USA. 90:1993;7656-7660.
21. 2 receptors. Mol. Pharmacol. 48:1995;443-450.
22. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 23:1993;313-314.
23. Friedman, H., Shivers, S.C. and Klein, T.W., Drugs of abuse and the immune system. In: J.H. Dean, M.I. Luster, A.E. Munson and I. Kimber (Eds.), Immunotoxicology and Immunopharmacology, Vol. 2, Raven, New York, 1994, pp. 303-322.
24. Galiègue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
25. Glass M., Dragunow M., Faull R.L.M. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 77:1997;299-318.
26. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
27. Herzberg U., Eliav E., Bennett G.J., Kopin I.J. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett. 221:1997;157-160.
28. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634.
29. Howlett A.C., Bidaut-Russell M., Devane W.A., Melvin L.S., Johnson M.R., Herkenham M. The cannabinoid receptor: biochemical, anatomical and behavioural characterisation. Trends Neurosci. 13:1990;420-423.
30. Jaggar S.I., Rice A.S.C. Thermal hyperalgesia is referred to the hind limb following inflammation of the urinary bladder in rat. Soc. Neurosci. Abstr. 23:1997;917.6.
31. 2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia, Pain, (1997) in press.
32. Kalso E., Tramer M.R., Carroll D., McQuay H.J., Moore R.A. Pain relief from intra-articular morphine after knee surgery: a qualitative systematic review. Pain. 71:1997;127-134.
33. Kaminski N.E., Abood M.E., Kessler F.K., Martin B.R., Schatz A.R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42:1992;736-742.
34. Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L., Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. USA. 91:1994;3739-3743.
35. Letourneau R., Sant G.R., El-Mansoury M., Theoharides T.C. Activation of bladder mast cells in interstitial cystitis. Int. J. Tissue Reac. XIV:1992;307-312.
36. Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19:1996;514-520.
37. Lewin G.R., Rueff A., Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 6:1994;1903-1912.
38. Lichtman A.H., Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258:1991;517-523.
39. Lundeberg T., Liedberg H., Nordling L., Theodorsson E., Owzarski A., Ekman P. Interstitial cystitis: correlation with nerve fibres, mast cells and histamine. Br. J. Urol. 71:1993;427-429.
40. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
41. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
42. Mazzari S., Canella R., Leon A. N-(2-Hydroxyethyl)hexadecanamide reduces mechanical hyperalgesia following sciatic nerve constriction injury. Soc. Neurosci. Abstr. 21:1995;652.
43. Mazzari S., Canella R., Petrelli L., Marcolongo G., Leon A. N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol. 300:1996;227-236.
44. McMahon S.B. Neuronal and behavioural consequences of chemical inflammation of the rat urinary bladder. Agents Actions. 25:1988;231-233.
45. McMahon S.B., Abel C. A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals. Pain. 28:1987;109-127.
46. McMahon S.B., Sykova E., Wall P.D., Woolf C.J., Gibson S. Neurogenic extravasation and substance P levels are low in muscle as compared to skin. Neurosci. Lett. 52:1984;235-240.
47. McMahon, S.B. and Bennett, D.L.H., Growth factors and pain. In: A.H. Dickenson, J. Besson (Eds.), The Pharmacology of Pain, Springer, Berlin, 1997, pp. 135-157.
48. McMahon, S.B., Bennett, D.L.H., Priestley, J.V. and Shelton, D.L., The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule, Nat. Med., 1 (1995a) 774-780.
49. McMahon, S.B., Dmitrieva, N. and Koltzenburg, M., Visceral pain, Br. J. Anaesth., 75 (1995b) 132-144.
50. Mechoulam R., Hanus L., Martin B.R. Search for endogenous ligands of the cannabinoid receptor. Biochem. Pharmacol. 48:1994;1537-1544.
51. Mechoulam R., Shabat S.B., Hanus L., Fride E., Vogel Z., Bayewitch M., Sulcova A.E. Endogenous cannabinoid ligands - chemical and biological studies. J. Lipid Mediat. Cell Signal. 14:1996;45-49.
52. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterisation of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
53. Natarajan V., Reddy P.V., Schmid P.C., Schmid H.H.O. N-Acylation of ethanolaminephospholipids in canine myocardium. Biochim. Biophys. Acta. 712:1982;342-355.
54. Oddiah D., McMahon S.B., Rattray M. Inflammation produces up-regulation of neurotrophin messenger RNA in bladder. Soc. Neurosci. Abstr. 21:1995;604.15.
55. Pertwee R. The evidence for the existence of cannabinoid receptors. Gen. Pharmacol. 24:1993;811-824.
56. 1 receptors in mouse urinary bladder. Br. J. Pharmacol. 18:1996;2053-2058.
57. Reggio P.H. Molecular determinants of cannabinoid activity: towards the design of cannabinoid analgesics with reduced psychoactive liability. NIDA Res. Monogr. 134:1993;210-228.
58. Rice A.S.C. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain. Neurosci. Lett. 187:1995;111-114.
59. Rice A.S.C., McMahon S.B. Pre-emptive intra-thecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral pain. Pain. 57:1994;335-340.
60. 1 receptors, Pain, (1998) in press.
61. Roach J.T., Broom S.L., Graham S.M., ElSohly M.A., Jones A.B., Ross S.A., Sufka K.J. Stimulus properties and antinociceptive effects of cannabinoids in models of inflammatory nociception in rats. Soc. Neurosci. Abstr. 22:1996;879.
62. Schafer M., Carter L., Stein C. Interleukin 1β and corticotrophin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. USA. 91:1994;4219-4223.
63. Shire D., Calandra D., Rinaldi-Carmona M., Oustric D., Pessegue B., Bonnin-Cabanne O., Le Fur G., Caput D., Ferrara P. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim. Biophys. Acta. 1307:1996;132-136.
64. Showalter L.A., Compton D.R., Martin B.R., Abood M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278:1996;989-999.
65. Skaper, S.D., Buriani, A., Dal Toso, R., Petrelli, L., Romanello, S., Facci, L. and Leon, A., The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons, Proc. Natl. Acad. Sci. USA, 93 (1996a) 3984-3989.
66. Skaper, S.D., Facci, L., Romanello, S. and Leon, A., Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway, J. Neurochem., 66 (1996b) 1157-1166.
67. Smith P.B., Compton D.R., Welch S.P., Razdan R.K., Mechoulam R., Martin B.R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270:1994;219-227.
68. Stein C. Peripheral mechanisms of opioid analgesia. Anesth. Analg. 76:1993;182-191.
69. Stein C., Millan M.J., Shippenberg T.S., Peter K., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 248:1989;1269-1275.
70. Stein, C., Gramsch, C. and Herz, A., Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and β-endorphin, J. Neurosci., 10 (1990a) 1292-1369.
71. Stein, C., Hassan, A.H.S., Przewlocki, R., Gramsch, C., Peter, K. and Herz, A., Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation, Proc. Natl. Acad. Sci. USA, 87 (1990b) 5935-5939.
72. Stein E.A., Fuller S.A., Edgemond W.S., Campbell W.B. Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br. J. Pharmacol. 119:1996;107-114.
73. Theoharides T.C. The mast cell: a neuroimmunoendocrine master player. Int. J. Tissue React. XVIII:1996;1-21.
74. Tjolsen A., Berge O., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain. 51:1992;5-17.
75. Watson G.F., Sufka K.J., Coderre T.J. Optimal scoring strategies and weights for the formalin test in rats. Pain. 70:1997;53-58.
76. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine in mice. J. Pharmacol. Exp. Ther. 262:1992;10-18.
77. Welch S.P., Dunlow L.D., Patrick G.S., Razdan R.K. Characterisation of anandamide- and fluoroanandamide-induced antinociception and cross tolerance to delta-9-THC after intrathecal administration to mice: blockade of delta-9-THC-induced antinociception. J. Pharmacol. Exp. Ther. 273:1995;1235-1244.
78. Woolf C.J., Safieh-Garabedian B., Ma Q., Crilly P., Winters J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 62:1994;327-331.